Cargando…
Field cancerization profile-based prognosis signatures lead to more robust risk evaluation in hepatocellular carcinoma
The development of reliable biomarkers has been an urgent issue as well as a hot spot of research on the diagnosis, treatment, and prognostic evaluation of hepatocellular carcinoma (HCC). Here, we established and validated two field cancerization profile-based prognostic signatures (gene expression...
Autores principales: | Huang, Lu, Songyang, Zhou, Dai, Zhiming, Xiong, Yuanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800113/ https://www.ncbi.nlm.nih.gov/pubmed/35118360 http://dx.doi.org/10.1016/j.isci.2022.103747 |
Ejemplares similares
-
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
por: Luo, Zhenhua, et al.
Publicado: (2019) -
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020) -
REIA: A database for cancer A-to-I RNA editing with interactive analysis
por: Zhu, Huimin, et al.
Publicado: (2022) -
Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023) -
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
por: Tang, Bufu, et al.
Publicado: (2020)